Definitive Healthcare Corp expected to post earnings of 8 cents a share - Earnings Preview

Definitive Healthcare

06/11/2024 03:52

* Definitive Healthcare Corp  DH.OQ   DH.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 7
for the period ending September 30 2024
    * The Framingham Massachusetts-based  company is expected to
report a 5.5% decrease in revenue to $61.724 million from $65.33
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Definitive Healthcare
Corp is
for earnings of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Definitive
Healthcare Corp is $5.00​, above​ its last closing price
of $4.12. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.09        0.09       0.09      Met     3.7
 Mar. 31 2024  0.08        0.08       0.08      Met     -1.9
 Dec. 31 2023  0.08        0.08       0.07      Missed  -8.4​
 Sep. 30 2023  0.07        0.06       0.09      Beat    49.1
 ​​Jun.        0.06        0.06       0.08      Beat    44.6
 30 2023                                                
 Mar. 31 2023  0.05        0.04       0.06      Beat    35​
 Dec. 31 2022  0.04        0.04       0.07      Beat    67.7
 Sep. 30 2022  0.05        0.05       0.06      Beat    27.7
 This summary was machine generated November 6 at 03:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)